Our results suggested that an intrabronchial injection of bone marrow stem cells (MSCs) was beneficial for relieving airway inflammation in CS-exposed rat models through the down-regulation of COX-2 and PGE2 synthesis. This evidence concerns the gene PTGS2 and Cowden syndrome 1.